Cargando…
CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing
OBJECTIVE: Enhanced de novo lipogenesis (DNL) in hepatocytes is a major contributor to nonalcoholic fatty liver disease (NAFLD). Fatty acid translocase (FAT/CD36) is involved in the pathogenesis of NAFLD through facilitating free fatty acids uptake. Here, we explored the effects of CD36 on DNL and e...
Autores principales: | Zeng, Han, Qin, Hong, Liao, Meng, Zheng, Enze, Luo, Xiaoqing, Xiao, Anhua, Li, Yiyu, Chen, Lin, Wei, Li, Zhao, Lei, Ruan, Xiong Z., Yang, Ping, Chen, Yaxi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810570/ https://www.ncbi.nlm.nih.gov/pubmed/34974159 http://dx.doi.org/10.1016/j.molmet.2021.101428 |
Ejemplares similares
-
Ammonia stimulates SCAP/Insig dissociation and SREBP-1 activation to promote lipogenesis and tumor growth
por: Cheng, Chunming, et al.
Publicado: (2022) -
CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis
por: Yang, Ping, et al.
Publicado: (2022) -
Circulating soluble CD36 as a novel biomarker for progression and prognosis of HBV-related liver diseases
por: Cai, Chunxian, et al.
Publicado: (2022) -
Hypomorphic ASGR1 modulates lipid homeostasis via INSIG1-mediated SREBP signaling suppression
por: Xu, Yingying, et al.
Publicado: (2021) -
Nifedipine Exacerbates Lipogenesis in the Kidney via KIM-1, CD36, and SREBP Upregulation: Implications from an Animal Model for Human Study
por: Lin, Yen-Chung, et al.
Publicado: (2020)